{
    "title": "ChatGPT in Drug Discovery: A Case Study on Anti-Cocaine Addiction Drug Development with Chatbots. (arXiv:2308.06920v2 [cs.AI] UPDATED)",
    "abstract": "The birth of ChatGPT, a cutting-edge language model-based chatbot developed by OpenAI, ushered in a new era in AI. However, due to potential pitfalls, its role in rigorous scientific research is not clear yet. This paper vividly showcases its innovative application within the field of drug discovery. Focused specifically on developing anti-cocaine addiction drugs, the study employs GPT-4 as a virtual guide, offering strategic and methodological insights to researchers working on generative models for drug candidates. The primary objective is to generate optimal drug-like molecules with desired properties. By leveraging the capabilities of ChatGPT, the study introduces a novel approach to the drug discovery process. This symbiotic partnership between AI and researchers transforms how drug development is approached. Chatbots become facilitators, steering researchers towards innovative methodologies and productive paths for creating effective drug candidates. This research sheds light on ",
    "link": "http://arxiv.org/abs/2308.06920",
    "context": "Title: ChatGPT in Drug Discovery: A Case Study on Anti-Cocaine Addiction Drug Development with Chatbots. (arXiv:2308.06920v2 [cs.AI] UPDATED)\nAbstract: The birth of ChatGPT, a cutting-edge language model-based chatbot developed by OpenAI, ushered in a new era in AI. However, due to potential pitfalls, its role in rigorous scientific research is not clear yet. This paper vividly showcases its innovative application within the field of drug discovery. Focused specifically on developing anti-cocaine addiction drugs, the study employs GPT-4 as a virtual guide, offering strategic and methodological insights to researchers working on generative models for drug candidates. The primary objective is to generate optimal drug-like molecules with desired properties. By leveraging the capabilities of ChatGPT, the study introduces a novel approach to the drug discovery process. This symbiotic partnership between AI and researchers transforms how drug development is approached. Chatbots become facilitators, steering researchers towards innovative methodologies and productive paths for creating effective drug candidates. This research sheds light on ",
    "path": "papers/23/08/2308.06920.json",
    "total_tokens": 1075,
    "translated_title": "ChatGPT在药物研发中的应用：以与聊天机器人开发抗可卡因成瘾药物为例的案例研究",
    "translated_abstract": "ChatGPT是OpenAI开发的一种基于语言模型的先进聊天机器人，它给人工智能带来了新的纪元。然而，由于潜在的缺陷，它在严格的科学研究中的作用尚不明确。本文生动展示了它在药物研发领域中的创新应用。研究专注于开发抗可卡因成瘾药物，利用GPT-4作为虚拟导引，为研究工作在候选药物的生成模型上提供战略和方法论的见解。主要目标是生成具有所需特性的最佳药物样子分子。通过利用ChatGPT的能力，本研究引入了一种新颖的药物研发方法。人工智能与研究人员之间的这种共生伙伴关系改变了药物研发的方法。聊天机器人成为促进者，引导研究人员走向创新的方法和创造有效药物候选的有成效途径。这项研究阐明了 AI 在现代药物研发中的作用。",
    "tldr": "本文以抗可卡因成瘾药物研发为例，展示了OpenAI开发的ChatGPT在药物研发领域的创新应用。通过利用GPT-4作为虚拟导引，ChatGPT为研究人员提供战略和方法论的见解，促进了创新的药物研发方法。这项研究揭示了AI在现代药物研发中的重要作用。"
}